Human macrophage metalloelastase worsens the prognosis of pancreatic cancer

Annals of Surgery

Volumn 235, Issue 4, 2002, Pages 519-527

  Balaz, Peter ^a   Friess, Helmut ^a,c   Kondo, Yasuo ^a   Zhu, Zhaowen ^a   Zimmermann, Arthur ^b   Büchler, Markus W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c Inselspital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE ELASTASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ELASTOLYSIS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; MOLECULAR BIOLOGY; NORTHERN BLOTTING; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 12; METALLOENDOPEPTIDASES; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0036211407     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200204000-00010     Document Type: Article

References (54)

1. Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints
2. Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin)
3. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages
4. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein
5. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase
6. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice
7. Macrophage infiltration and tumor progression
8. Macrophages and cancer
9. The origin and function of tumor-associated macrophages
10. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma
11. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression
12. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
13. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations
14. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration
15. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints
16. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer
17. Expression of matrix metalloproteinases and their inhibitors in human brain tumors
18. Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: Correlation with angiostatin generation and its clinical significance
19. Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma
20. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
21. Matrix metalloproteinases generate angiostatin: Effects on neovascularization
22. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
23. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
24. Proteinase activated receptor-1 regulation of macrophage elastase secretion by serine proteinases
25. Protein kinase C-alpha modulates lipopolysaccharide-induced functions in a murine macrophage cell line
26. Transforming growth factorbetas and their signaling receptors are coexpressed in Crohn's disease
27. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
28. bax, but not bcl-2, influences the prognosis of human pancreatic cancer
29. A subgroup of patients with chronic pancreatitis overexpress the c-erbB-2 protooncogene
30. Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas
31. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma
32. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
33. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
34. Angiostatin generation by human pancreatic cancer
35. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells
36. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma
37. Expression of membrane-type matrix metalloproteinase-1 in human pancreatic adenocarcinomas
38. Expression of the MMP-1 in human pancreatic carcinoma: Relationship with prognostic factor
39. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers
40. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases
41. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer
42. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma
43. Role of MT-MMPs and MMP-2 in pancreatic cancer progression
44. Expression on collagenase (MMP2), stromelysin (MMP3), and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease
45. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma
46. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas
47. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer
48. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: Implications for tumor progression and clinical prognosis
49. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer
50. Clinical potential of matrix metalloproteinase inhibitors in cancer therapy
51. Matrix metalloproteinases: Multifunctional contributors to tumor progression
52. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
53. Phase I study of the matrix metalloproteinase inhibitor, BAY12-9566